|
|
40
|
|
|
50411
|
|
|
ELOXATIN 50MG SOLN (SFA/COL) OXALIPLATIN
|
|
|
OXALIPLATIN
|
|
|
ELOXATIN
|
|
|
50MG VIAL
|
|
|
BQ
|
|
|
67.96
|
|
|
67.96
|
|
|
50MG
|
|
|
SOLUTION
|
|
|
0
|
|
|
VIAL
|
|
|
SFA
|
|
|
SANOFI AVENTIS
|
|
|
COL
|
|
|
COLLINS LTD
|
|
|
|
|
|
Anti-Neoplastic
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
No
|
|
|
1000
|
|
|
ANTINEOPLASTICS
|
|
|
|
|
|
IV
|
|
|
0
|
|
|
ANTINEOPLASTICS
|
|
|
|